Shrikanth Chomanahalli Basavarajappa

Also affiliated with Trinity College Dublin, Children's Health Ireland at Crumlin

Biochemistry, Genetics and Molecular BiologyMedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “HBD-2 binds SARS-CoV-2 RBD and blocks viral entry: Strategy to combat COVID-19”.

HBD-2 binds SARS-CoV-2 RBD and blocks viral entry: Strategy to combat COVID-19

iScience(2022)10.1016/j.isci.2022.103856

N/A

0.568DataRank · unranked

43 citations

Santosh K. Ghosh, Shrikanth Chomanahalli Basavarajappa, Yinghua Chen, Pravesh Shrestha, Jackson Penfield +5 more

Molecular dynamics simulations and functional studies reveal that hBD-2 binds SARS-CoV-2 spike RBD and blocks viral entry into ACE2 expressing cells

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.01.07.425621

N/A

0.489DataRank · unranked

25 citations

Santosh K. Ghosh, Shrikanth Chomanahalli Basavarajappa, Jeannine Muller‐Greven, Jackson Penfield, Ann M. Brewer +4 more

Trimeric receptor-binding domain of SARS-CoV-2 acts as a potent inhibitor of ACE2 receptor-mediated viral entry

iScience(2022)10.1016/j.isci.2022.104716

N/A

0DataRank · unranked

14 citations

Angela Rose Liu, Anna Bruchez, Zhen‐lu Li, Vinicius G. Suzart, Zhonghua Liu +5 more

Inhibition of SARS-CoV-2 infection in cellular systems using engineered trimeric receptor-binding domain of spike protein

STAR Protocols(2023)10.1016/j.xpro.2023.102127

N/A

0DataRank · unranked

0 citations

Shrikanth Chomanahalli Basavarajappa, Nandini Sarkar, Anna Bruchez, Parameswaran Ramakrishnan, Angela Rose Liu